| | 
Part, Chapter, Paragraph
1501 III, 10. 2. 3 | references, see Chapter 5.2.~ ~ ~
1502 III, 10. 2. 4 | 10.2.4.5. Future developments~ ~Insofar,
1503 III, 10. 2. 5 | 10.2.5. Developmental factors and
1504 III, 10. 2. 5 | 10.2.5.1. Introduction~Adult physical
1505 III, 10. 2. 5 | 10.2.5.2. Data sources~ ~Data on
1506 III, 10. 2. 5 | 10.2.5.3. Data description and
1507 III, 10. 2. 5 | 10.2.5.4. Control tools and policies~ ~
1508 III, 10. 2. 5 | 10.2.5.5. Future developments~ ~
1509 III, 10. 2. 5 | 10.2.5.5. Future developments~ ~Current
1510 III, 10. 2. 5 | 10.2.5.6. References~Allen JP,
1511 III, 10. 3. 1 | evening (19-23 hours) with 5 dB(A) and those during the
1512 III, 10. 3. 1 | facilitated, e.g. per sources and 5 dB band of sound level along
1513 III, 10. 3. 1 | 10.3.1.5. Future developments~ ~For
1514 III, 10. 3. 2 | chemicals25 increased by 23.5%. The substances of high
1515 III, 10. 3. 2 | released into water bodies (-14.5%), the various types of
1516 III, 10. 3. 2 | emission of dioxins/furans (-22.5%) into the atmosphere. An
1517 III, 10. 3. 2 | mining accounted for 53.5% of all exports in 2004.~ ~
1518 III, 10. 3. 2 | pollution (PM), mainly PM2.5 or less~smoking and environmental
1519 III, 10. 3. 2 | inhalable particles (PM2.5 and PM10 )~ground-level
1520 III, 10. 3. 2 | concentrations was in the order of 5% or more per year, higher
1521 III, 10. 3. 2 | about 10 pg/g (range of 5-20) in most countries. There
1522 III, 10. 3. 2 | 10.3.2.5. Future developments~ ~The
1523 III, 10. 3. 3 | 10.3.3.5. Future developments~ ~See
1524 III, 10. 3. 4 | 10.3.4.5. Future developments~ ~Since
1525 III, 10. 4. 1 | health damage due to PM2.5 and the effect of the implementation
1526 III, 10. 4. 1 | health damage due to PM2.5 in the EU 2000 and through
1527 III, 10. 4. 1 | usually measured as PM2.5 ) have serious effects on
1528 III, 10. 4. 1 | results indicate that PM2.5 levels in Europe are now
1529 III, 10. 4. 1 | lower respiratory tract (PM2.5 ), ozone (O3 ), nitrogen
1530 III, 10. 4. 1 | particulate matter (PM2.5 ) alone. This corresponds
1531 III, 10. 4. 1 | anthropogenic contributions to PM2.5., 2000 and 2020 is mapped
1532 III, 10. 4. 1 | ISAAC) varied from less than 5% to over 20%. The societal
1533 III, 10. 4. 1 | Emissions of fine particles (PM2.5 ), NH3 , NOx, SO2 and VOCs
1534 III, 10. 4. 1 | adding a new standard for PM2.5 – with the so-called concentration
1535 III, 10. 4. 1 | 10.4.1.5. Future developments~ ~The
1536 III, 10. 4. 1 | Environment News Alert. 5 December 2005.~ ~Holland,
1537 III, 10. 4. 2 | 4) biological hazards; (5) contaminants in the food
1538 III, 10. 4. 2 | Decreasing in eggs over the last 5 years34. Around one in five
1539 III, 10. 4. 2 | table eggs over the last 5 years.~· Relatively high
1540 III, 10. 4. 2 | 2001, from 2,900 samples~3.5% (the Netherlands) and~13% (
1541 III, 10. 4. 2 | preparation~ ~Intake in 5% of the~Population such
1542 III, 10. 4. 2 | rough estimation about 7.5 millions of individual data
1543 III, 10. 4. 2 | consumer’s health (Table 10.4.2.5).~ ~Nitrates~ ~In Europe,
1544 III, 10. 4. 2 | 2007b).~ ~ ~Table 10.4.2.5. Naturally occurring, potentially
1545 III, 10. 4. 2 | expert meetings “covering the 5 areas of the data requirements
1546 III, 10. 4. 2 | by Directive 2001/18/EC (5) on the deliberate release
1547 III, 10. 4. 2 | law principles (Articles 5 to 10) and requirements (
1548 III, 10. 4. 2 | 10.4.2.5. Future developments~ ~While
1549 III, 10. 4. 2 | Communities No. L 287/1, 5 November 2003. Available
1550 III, 10. 4. 3 | Deaths among children under 5 years of age due to diarrheal
1551 III, 10. 4. 3 | diseases in children under 5 years of age fell from 70.
1552 III, 10. 4. 3 | 176.3 to 44.6 in the CARK (5 Central Asian Republics
1553 III, 10. 4. 3 | central Asia. An average of 66.5% of the population in European
1554 III, 10. 4. 3 | 10.4.3.5. Future developments~ ~A
1555 III, 10. 4. 4 | piercing see Annex 1 of Chapter 5.13.~ ~The increasing production,
1556 III, 10. 4. 5 | 10.4.5. Multiple exposure: bathing
1557 III, 10. 4. 5 | 10.4.5.1. Bathing water~ ~ ~Acronyms~ ~
1558 III, 10. 4. 5 | European standards (Figure 10.4.5.1.1. A and B) (EEA, 2008).~ ~
1559 III, 10. 4. 5 | EEA, 2008).~ ~Figure 10.4.5.1.1.a. Bathing water. Compliance
1560 III, 10. 4. 5 | coastal water~ ~Figure 10.4.5.1.1.b. Bathing water. Compliance
1561 III, 10. 4. 5 | 10.4.5.2. Soil pollution and waste
1562 III, 10. 4. 5 | chemicals (see Figure 10.4.5.2.1; EEA, 2007a).~ ~Soil
1563 III, 10. 4. 5 | EEA, 2007b).~ ~Figure 10.4.5.2.1. Overview of the activities
1564 III, 10. 4. 5 | average waste generation of 5- 20 tonnes per capita per
1565 III, 10. 4. 5 | generation increased by 5% between 1996 and 2004 in
1566 III, 10. 4. 5 | municipal waste (Figure 10.4.5.2.2). However, the single
1567 III, 10. 4. 5 | of Germany.~ ~Figure 10.4.5.2.2a. Total waste generation
1568 III, 10. 4. 5 | EECCA 2004)~ ~Figure 10.4.5.2.2b. Total waste generation
1569 III, 10. 4. 5 | EU-10, 2004)~ ~Figure 10.4.5.2.2c. Total waste generation
1570 III, 10. 4. 5 | dominant producer (Figure 10.4.5.2.3). The large differences
1571 III, 10. 4. 5 | comparable.~ ~Figure 10.4.5.2.3. Hazardous waste generation
1572 III, 10. 4. 5 | contamination~ ~Figure 10.4.5.2.4. Overview of progress
1573 III, 10. 4. 5 | in Europe~ ~Figure 10.4.5.2.5. Breakdown of activities
1574 III, 10. 4. 5 | Europe~ ~Figure 10.4.5.2.5. Breakdown of activities
1575 III, 10. 4. 5 | per country~ ~Figure 10.4.5.2.6. Detailed analysis of
1576 III, 10. 4. 5 | per country~ ~Figure 10.4.5.2.7. Overview of contaminants
1577 III, 10. 4. 5 | groundwater in Europe~ ~Table 10.4.5.2.1. Overview of contaminants
1578 III, 10. 4. 5 | are available (Figure 10.4.5.2.4).~ ~The distribution
1579 III, 10. 4. 5 | investigated sites (Figure 10.4.5.2.5).~ ~At industrial and
1580 III, 10. 4. 5 | investigated sites (Figure 10.4.5.2.5).~ ~At industrial and commercial
1581 III, 10. 4. 5 | inventories ((Figure 10.4.5.2.6).~ ~The range of contaminants
1582 III, 10. 4. 5 | contaminants in Europe (Figure 10.4.5.2.7). These estimates are
1583 III, 10. 4. 5 | hydrocarbons (CHC) (Table 10.4.5.2.1). Mineral oil and chlorinated
1584 III, 10. 4. 5 | comprising approximately 0.5%. In 2003, the WHO exposure
1585 III, 10. 5 | 10.5. LIVING AND WORKING ENVIRONMENT~ ~ ~
1586 III, 10. 5. 1 | 10.5.1. Houses, schools, transports,
1587 III, 10. 5. 1 | 10.5.1.1. Introduction~ ~The
1588 III, 10. 5. 1 | 10.5.1.2. Data sources~ ~The
1589 III, 10. 5. 1 | 10.5.1.3. Data description and
1590 III, 10. 5. 1 | 10.5.1.3.1. Residential buildings~ ~
1591 III, 10. 5. 1 | 30% (Portugal) to under 5% (Finland), with an average
1592 III, 10. 5. 1 | 10.5.1.3.2. Schools~ ~For children,
1593 III, 10. 5. 1 | 10.5.1.5. Recreational areas
1594 III, 10. 5. 1 | 10.5.1.5. Recreational areas and
1595 III, 10. 5. 1 | 10.5.1.6. Transport~ ~The need
1596 III, 10. 5. 1 | population.~ ~Figure 10.5.1.1. Proportion of residents
1597 III, 10. 5. 1 | EEA, 2006b).~ ~Figure 10.5.1.2. Concentrations of elemental
1598 III, 10. 5. 1 | compounds, PM10 and PM2.5 in relation to settlement
1599 III, 10. 5. 1 | 10.5.1.6. Other issues~ ~Household
1600 III, 10. 5. 1 | respiratory causes decreased by 15.5% and deaths from cardiovascular
1601 III, 10. 5. 1 | 10.5.1.7. Control tools and policies~ ~
1602 III, 10. 5. 1 | socio-economic groups.~ ~Figure 10.5.1.3. Housing problems by
1603 III, 10. 5. 1 | indicated average.~ ~Figure 10.5.1.4. Crowding by income
1604 III, 10. 5. 1 | 10.5.1.8. References~Bagaeen
1605 III, 10. 5. 1 | Cities. Vol. 23. Issue 5. P. 339–352.~Bayerisches
1606 III, 10. 5. 1 | 2002 Oct 19;360(9341):1184-5.~Daisey JM, Angell WJ and
1607 III, 10. 5. 1 | 10.5.1.9. Acronyms~ ~CO~Carbon
1608 III, 10. 5. 2 | 10.5.2. Urban and rural populations~ ~
1609 III, 10. 5. 2 | 10.5.2.1. Introduction~ ~When
1610 III, 10. 5. 2 | structures.~ ~Figure 10.5.2.1. Population distribution
1611 III, 10. 5. 2 | 10.5.2.2. Data sources~ ~The
1612 III, 10. 5. 2 | 10.5.2.3. Data description and
1613 III, 10. 5. 2 | difference for Italy (27,5% versus 30%). However, in
1614 III, 10. 5. 2 | recreational areas (Figures 10.5.2.2-10.5.2.4).~ ~Figure
1615 III, 10. 5. 2 | areas (Figures 10.5.2.2-10.5.2.4).~ ~Figure 10.5.2.2.
1616 III, 10. 5. 2 | 2-10.5.2.4).~ ~Figure 10.5.2.2. Complaints by residents
1617 III, 10. 5. 2 | environmental conditions~ ~Figure 10.5.2.3. Complaints due to air
1618 III, 10. 5. 2 | rural settings~ ~Figure 10.5.2.4. Complaint about access
1619 III, 10. 5. 2 | and females.~ ~Figure 10.5.2.5. Correlation of age-adjusted
1620 III, 10. 5. 2 | females.~ ~Figure 10.5.2.5. Correlation of age-adjusted
1621 III, 10. 5. 2 | rural settlements, males~ ~Figure 10.5.2.6. Correlation between
1622 III, 10. 5. 2 | et al., 2007).~ ~Table 10.5.2.1. Variations in cause
1623 III, 10. 5. 2 | population.~ ~Figure 10.5.2.7. Life expectancy by
1624 III, 10. 5. 2 | Lithuania, 2006~ ~Figure 10.5.2.8. Mortality rates in
1625 III, 10. 5. 2 | than in rural settings (63.5 years). For female children,
1626 III, 10. 5. 2 | member States.~ ~Figure 10.5.2.9. Self-reported health
1627 III, 10. 5. 2 | EU in 2004.~ ~Figure 10.5.2.10. Long-standing illness
1628 III, 10. 5. 2 | preventive actions.~ ~Figure 10.5.2.11. Health problems in
1629 III, 10. 5. 2 | rural settings.~ ~Figure 10.5.2.12. Infection prevalence
1630 III, 10. 5. 2 | rural and urban settings (8.5%), while for boys the prevalence
1631 III, 10. 5. 2 | urbanization levels:~ ~Table 10.5.2.2. Percentage and total
1632 III, 10. 5. 2 | countries.~ ~ ~Table 10.5.2.3. Problems accessing
1633 III, 10. 5. 2 | 10.5.2.4. Control tool and policies~ ~
1634 III, 10. 5. 2 | 10.5.2.5. Future developments~ ~
1635 III, 10. 5. 2 | 10.5.2.5. Future developments~ ~Although
1636 III, 10. 5. 2 | 10.5.2.6. References~ ~British
1637 III, 10. 5. 2 | Rural and Remote Health 5, on-line article n. 323,
1638 III, 10. 5. 2 | 10.5.2.7. Acronyms~ ~BMA~British
1639 III, 10. 5. 3 | 10.5.3. Workplace~ ~
1640 III, 10. 5. 3 | 10.5.3.1. Introduction~ ~In modern
1641 III, 10. 5. 3 | 10.5.3.2 Data sources~ ~ ~It
1642 III, 10. 5. 3 | 10.5.3.3 Data description and
1643 III, 10. 5. 3 | once in 12 months (Table 10.5.3.1). This results on an
1644 III, 10. 5. 3 | results on an average of 4.5 days per worker and 20 days
1645 III, 10. 5. 3 | social work.~ ~Table 10.5.3.1. Absence from work in
1646 III, 10. 5. 3 | billion. Additionally, 268.5 million working days were
1647 III, 10. 5. 3 | 1900 fatal events (table 10.5.3.2). The incidence rate
1648 III, 10. 5. 3 | tunnel syndrome (Table 10.5.3.3).~Economic sectors are
1649 III, 10. 5. 3 | occupational diseases (table 10.5.3.4). A top incidence rate
1650 III, 10. 5. 3 | per 100,000.~ ~Table 10.5.3.2. Number and incident
1651 III, 10. 5. 3 | occupational diseases.~ ~Table 10.5.3.3. Number of non fatal
1652 III, 10. 5. 3 | diseases by ICD10.~ ~Table 10.5.3.4. Number and incident
1653 III, 10. 5. 3 | compensation was due to only 5 disease groups. Among these,
1654 III, 10. 5. 3 | serious accidents) (Table 10.5.3.5) and accidents which
1655 III, 10. 5. 3 | accidents) (Table 10.5.3.5) and accidents which leads
1656 III, 10. 5. 3 | also Chapter 7.~ ~Table 10.5.3.5. Incidence of work accidents
1657 III, 10. 5. 3 | Chapter 7.~ ~Table 10.5.3.5. Incidence of work accidents
1658 III, 10. 5. 3 | the year 2000.~ ~Table 10.5.3.6 gives time trends with
1659 III, 10. 5. 3 | economic sectors. Table 10.5.3.7 points to especially
1660 III, 10. 5. 3 | work increased.~ ~Table 10.5.3.6. Change in the number
1661 III, 10. 5. 3 | 1994 to 2004~ ~Table 10.5.3.7. Standardised incidence
1662 III, 10. 5. 3 | of their work (table 10.5.3.8). This perceived impact
1663 III, 10. 5. 3 | stress and headache (table 10.5.3.9). There seems to be
1664 III, 10. 5. 3 | between sexes. Table 10.5.3.10 finally gives the prevalence
1665 III, 10. 5. 3 | of their work.~ ~Table 10.5.3.8. Perceived impact of
1666 III, 10. 5. 3 | health per country~ ~Table 10.5.3.9. Perceived impact of
1667 III, 10. 5. 3 | per symptoms.~ ~Table 10.5.3.10. Perceived work-related
1668 III, 10. 5. 3 | work economies. Figure 10.5.3.1 summarizes the European
1669 III, 10. 5. 3 | Eurostat, 2006):~· 197.5 million people resident
1670 III, 10. 5. 3 | to 64 years old) was 42.5% in 2005, up by 5.9 percentage
1671 III, 10. 5. 3 | was 42.5% in 2005, up by 5.9 percentage points since
1672 III, 10. 5. 3 | those working part-time. 14.5% of them hold a contract
1673 III, 10. 5. 3 | with limited duration (19.5% in Portugal, 25.7% in Poland,
1674 III, 10. 5. 3 | Poland, 33.3% in Spain).~· 19.5 million people were unemployed (
1675 III, 10. 5. 3 | economically inactive.~ ~Figure 10.5.3.1. Work status of people
1676 III, 10. 5. 3 | men than women (table 10.5.3.11). About 40% of all
1677 III, 10. 5. 3 | repetitive tasks.~ ~Table 10.5.3.11. Work organisational
1678 III, 10. 5. 3 | and agriculture (table 10.5.3.12). A lack of job control
1679 III, 10. 5. 3 | communication.~ ~Table 10.5.3.12. Work organisational
1680 III, 10. 5. 3 | physical risk factors (table 10.5.3.13). Exposures to vibrations
1681 III, 10. 5. 3 | economic sectors (table 10.5.3.14). Especially employees
1682 III, 10. 5. 3 | working time.~ ~Table 10.5.3.13. Physical risks factors
1683 III, 10. 5. 3 | work per gender.~ ~Table 10.5.3.14. Physical risks factors
1684 III, 10. 5. 3 | 2030 (older workers + 15.5%, young adults -10%).~A
1685 III, 10. 5. 3 | 10.5.3.4. Control tools and policies~ ~
1686 III, 10. 5. 3 | economic loss amounting to 4–5% of GDP. Estimates expect
1687 III, 10. 5. 3 | return-on-investment of up to 1:5. This means that for every
1688 III, 10. 5. 3 | the programme, potentially 5 € could be saved due to
1689 III, 10. 5. 3 | 10.5.3.5. Future developments~ ~
1690 III, 10. 5. 3 | 10.5.3.5. Future developments~ ~Diseases
1691 III, 10. 5. 3 | 10.5.3.6. References~ ~Aldana
1692 III, 10. 5. 3 | Journal of Health Promotion 15(5):296-320.~Andlin-Sobocki
1693 III, 10. 5. 3 | 10.5.3.7. Acronyms~ ~ENWHP~European
1694 III, 10. 6. 1 | 10.6.2.5 The World Values Survey~
1695 III, 10. 6. 1 | al, 2005).~ ~Figure 10.6.5. Exposures to assaults and
1696 III, 10. 6. 1 | 10.6.1.5. Future developments~ ~Social
1697 III, 10. 6. 1 | Children and Adolescents, No. 5). Available also online
1698 III, 10. 6. 2 | Healthier working life~5. Healthy and safe environments
1699 III, 10. 6. 2 | 10.6.2.5. Future developments~ ~By
1700 III, 10. 6. 3 | EU27 and in particular for 5% in the 1-4 years age group.
1701 III, 10. 6. 3 | from females. On average, 0.5% of male respondents recorded
1702 III, 10. 6. 3 | are lacking (see Tables 9.5.5 and 9.5.6). Not all assaults
1703 III, 10. 6. 3 | lacking (see Tables 9.5.5 and 9.5.6). Not all assaults
1704 III, 10. 6. 3 | see Tables 9.5.5 and 9.5.6). Not all assaults result
1705 III, 10. 6. 3 | 10.6.3.5. References~ ~EUICS (2005):
1706 IV, 11. 1. 5 | Netherlands, compared to 94.5% in Italy. Various approaches
1707 IV, 11. 1. 5 | Austria and Switzerland (6.5 and over), the lowest in
1708 IV, 11. 1. 5 | and Hungary (less than 3.5) (See Figure 11.1). In most
1709 IV, 11. 1. 6 | insurance systems, around 3-5% in most countries. It can
1710 IV, 11. 2. 1 | Austria and Cyprus (7.5%). Despite the general trend
1711 IV, 11. 2. 1 | most countries (Table 11.5). The exceptions are Germany,
1712 IV, 11. 2. 1 | was seen.~ ~F ~ ~Table 11.5. Number of psychiatric beds
1713 IV, 11. 2. 2 | the Netherlands (from 3.5% to 4.7%) (OECD Health data
1714 IV, 11. 2. 2 | lowest levels of under 2.5% and 3% in CEE countries (
1715 IV, 11. 3. 1 | medical school in Europe is 5-6 years, with residency
1716 IV, 11. 3. 2 | in percentage points of 2.5 in Austria (between 1995
1717 IV, 11. 3. 2 | the period 1996 to 2004/5 in some countries, including
1718 IV, 11. 3. 2 | priority diseases.~ ~Figure 11.5. Current levels of research
1719 IV, 11. 3. 2 | anti-neoplastic agents (figure 11.5).~ ~Therapeutic focus of
1720 IV, 11. 5 | 11.5. Tissue, cell and organ
1721 IV, 11. 5. 1 | 11.5.1. Introduction~ ~Over the
1722 IV, 11. 5. 2 | 11.5.2. Data sources~ ~A number
1723 IV, 11. 5. 3 | 11.5.3. European survey on donation
1724 IV, 11. 5. 4 | 11.5.4. Organ shortage~ ~The
1725 IV, 11. 5. 4 | transplant activity and 5% of liver transplantation.
1726 IV, 11. 5. 5 | 11.5.5. Research in the transplantation
1727 IV, 11. 5. 5 | 11.5.5. Research in the transplantation
1728 IV, 11. 5. 6 | 11.5.6. Policy tools~ ~European
1729 IV, 11. 5. 6 | Recommendation No. R (97) 5 on the protection of medical
1730 IV, 11. 5. 6 | Organisation Resolution WHA 42.5 condemning the purchase
1731 IV, 11. 5. 7 | 11.5.7. Future developments~ ~
1732 IV, 11. 6. 1 | spending accounted for just 5% of GDP. By 1990, this share
1733 IV, 11. 6. 2 | insurance funds, but only 5 when one considers that
1734 IV, 11. 6. 2 | countries it remains well below 5% of total expenditure. Spending
1735 IV, 11. 6. 2 | accounting for less than 5% in Greece, Italy and Portugal,
1736 IV, 11. 6. 2 | with a rise of more than 5 percentage points in Belgium,
1737 IV, 11. 6. 2 | recorded a fall of over 5 percentage points in the
1738 IV, 11. 6. 2 | day ranging from about €5-10 in Austria, France, Germany
1739 IV, 11. 6. 2 | payments sometimes, while 5.7% made payments on almost
1740 IV, 11. 6. 4 | Finance~Ministry of Health~5 regional health authorities~
1741 IV, 11. 6. 4 | hypertension, TB, AIDS (84.5% based on historical spend)~
1742 IV, 11. 6. 4 | and rural costs)~Slovakia~5 health insurance companies~
1743 IV, 11. 6. 4 | HMRC)~Department of Health~5 health authorities (geographically
1744 IV, 11. 6. 5 | in Health Care 14(1): 4-5.~ ~Marshall MN, Shekelle
1745 IV, 11. 6. 5 | Pharmacoeconomics & Outcomes Research 5(1): 81-93.~ ~Mrazek M, Mossialos
1746 IV, 11. 6. 5 | Health Services Research 39(5): 1589-606.~ ~Robinson R,
1747 IV, 11. 6. 5 | of Economic Perspectives 5(2): 45-66.~ ~Schreyogg J,
1748 IV, 11. 6. 5 | Quality in Health Care 5:159-65.~ ~Wilson RM, Runciman
1749 IV, 12. 1 | medical care (Article 152 (4.5).~ ~Even when a “public
1750 IV, 12. 1 | set out in this Article.~5. Community action in the
1751 IV, 12. 2 | policies (see also Chapter 11.5) and global health issues.
1752 IV, 12. 2 | see Tables 12.4 and 12.5.~ ~Table 12.4. Policies
1753 IV, 12. 2 | pre-cancer lesions (with 3 or 5 years of interval); women
1754 IV, 12. 2 | in 2007. ~ ~ ~ ~Table 12.5. Policies and control tools
1755 IV, 12. 2 | efforts, WHO finds that only 5% of the world’s population
1756 IV, 12. 2 | the report include:~ ~Only 5% of the global population
1757 IV, 12. 2 | hospitals and schools;~Only 5% of the world’s population
1758 IV, 12. 2 | nine countries, covering 5% of the world’s people;~
1759 IV, 12. 3 | EU and covering some 14.5 million employees;~· public
1760 IV, 12. 5 | 12.5. The European Public Health
1761 IV, 12. 5 | with a budget of € 321.5 million. The new Programme’
1762 IV, 12. 5 | rapidly in emergencies.~ ~1.1.5. Develop strategies and
1763 IV, 12. 5 | as set out in Article 152(5) of the Treaty.~ ~1.2.3.
1764 IV, 12. 5 | If we consider a gain of 5% between 1995 and 2001 to
1765 IV, 12. 5 | compression and a loss of 5% to signify expansion then
1766 IV, 12. 7 | during the PT Presidency on 5-6 November 2007 launched
1767 IV, 12. 10 | 2007.~ ~Approximately € 2.5 mill. was in 2007 allocated
1768 IV, 12. 10 | Increases in tobacco taxes (5 steps between 2002 and 2005).~
1769 IV, 12. 10 | free working environment (§ 5 Health and Safety at work
1770 IV, 12. 10 | Arbeitsschutzgesetz, esp. §3 (1) ArbSchG, §5 (1) ArbSchG); health protection
1771 IV, 12. 10 | comments 10.2.4 and 10.2.5!~Obesity is subject to Federal
1772 IV, 12. 10 | support this phase.~o The last 5-6 years citizens are encouraged
1773 IV, 12. 10 | businesses and employees by:~5. promoting lifelong learning
1774 IV, 12. 10 | Decree-Law nb 178/2006 of 5 September;~Decree-Law nb
1775 IV, 12. 10 | equity in service provision, 5) prevention of marginalisation
1776 IV, 12. 10 | mental or abuse problems, 5) occupational health promotion,
1777 IV, 12. 10 | linked to objective domains 1-5.~ ~Most of these 16 policy
1778 IV, 12. 10 | levels~Domain of objective 5~ ~Environmental policy~Energy
1779 IV, 12. 10 | consumption~Domain of objective 5~ ~Environmental policy~Public
1780 IV, 12. 10 | cases~Domain of objective 5~ ~Environmental policy~Child
1781 IV, 12. 10 | housing~Domain of objective 5~ ~Housing policy~Environmental
1782 IV, 12. 10 | levels~Domain of objective 5~ ~Housing policy~Environmental
1783 IV, 12. 10 | environments~Domain of objective 5~ ~Protection against accidents
1784 IV, 12. 10 | groups~ ~Domain of objective 5~ ~Consumer policy~Child
1785 IV, 12. 10 | Healthier working life~5. Healthy and safe environments
1786 IV, 12. 10 | National level~ ~During last 5 years regulations regarding
1787 IV, 13.Acr | Netherlands (from 2.8% in 1990 to 5% in 2004). Very low levels
1788 IV, 13.Acr | prevention accounting for about 0.5% of total health spending
1789 IV, 13. 2. 1 | a weighting factor of 0.5, this means that a year
1790 IV, 13. 2. 2 | diseases are shown in Table 13.5.~ ~ ~Table 13.3. Additional
1791 IV, 13. 2. 2 | pollution accounted for 5% of all deaths and 3% of
1792 IV, 13. 2. 2 | nutrition accounted for 4.5% of all DALYs (disability-adjusted
1793 IV, 13. 2. 3 | highest disease burden, i.e. 9.5%. Estimations of environmental
1794 IV, 13. 2. 3 | pollution accounted for 5% of all deaths and 3 % of
1795 IV, 13. 2. 3 | different people.~ ~ ~Table 13.5. Annual health loss (in
1796 IV, 13. 2. 3 | cancers~100,000-300,000~5 dietary factors together,
1797 IV, 13. 2. 3 | tract infections, HIV/AIDS (5), stomach and intestinal
1798 IV, 13. 2. 3 | meningitis, bacterial STDs (5), tuberculosis~300-1,000~ ~
1799 IV, 13. 2. 3 | 300~ ~STEC 0175 (5)~PAHs (5) other substances~ ~
1800 IV, 13. 2. 3 | 300~ ~STEC 0175 (5)~PAHs (5) other substances~ ~Various
1801 IV, 13. 2. 3 | seventh (right-hand) column.~5. HIV/AIDS: Human Immunodeficiency
1802 IV, 13. 5 | 13.5. Demands on healthcare services~ ~
1803 IV, 13. 5 | prevalence doubling for every 5-year age group after the
1804 IV, 13. 6. 2 | 13.6.2.5 Child Health Service Quality~ ~
1805 IV, 13. 7. 3 | ERC is funded with EUR 7.5 billion over 7 years, it
1806 IV, 13. 7. 5 | 13.7.5. Personal data protection
|
|
| |
